This work reports on the synthesis, crystal structural determination, conformational analysis and antiproliferative activity of an alkylsulfonamide analogue of capsaicin -RPF151 (N-(benzo[d] [1,3]dioxol-5-ylmethyl)butane-1-sulfonamide). Capsaicin is the primary pungent and irritating natural product present in a variety of red chilli peppers of the genus Capsicum, and was reported to selectively inhibit the growth and to induce apoptosis in a wide variety of tumour cell lines.1-3 RPF151 was obtained by a simple reaction of 1-butanesulfonyl chloride with piperonylamine, in an anhydrous DCM (dichloromethane) and TEA (tetraethylammonium) mixture (Yield 70%). The crystal structure determination was carried out by means of an ab initio simulated annealing approach using X-ray powder diffraction data. RPF151 crystallized under a monoclinic system (P21/a) with final unit cell parameters refined using the Rietveld ethod: a = 29 0171 1 ) Å b = 10 7 5 ) Å c = 9 1117 ) Å β = 10 268 )° V = 268 98 17) Å Z = 8 Z' = 2 he statistical parameter as well as R-factors were: χ2 = 1 11 Rwp = 00 6 Rexp = 0 0 2 and RBragg = 0 010 he molecules are held together along the c-axis by hydrogen bonds involving the atoms N(37)-H(42)···O(4). Calculated elemental analysis for C12H17NO4S (271.09 g mol-1) shows C = 53.12, H = 6.32 and N = 5.16 while experimental values are C = 53.13, H = 6.39 and N = 5 1 he effects of RPF151 10 μM on human umbilical vein endothelial cells (HUVEC) proliferation was tested by flow cytometry. It was verified that RPF151 induced changes on cell morphology, a fact corroborated by HUVEC cell size and complexity. Furthermore, it caused a significant reduction on cell proliferation and evidenced no cytotoxic effects. Therefore, RPF151 could be developed as a candidate to an anti-angiogenic drug for the fighting against cancer. Acknowledgments: We are grateful to FAPESP (proc. nr.: 2013 FAPESP (proc. nr.: /18160-4, 2012 FAPESP (proc. nr.: /23233-8 and 2008 , CNPq (proc. nr. 305186/2012-4 and 477296/2011-4 ) and Provost's Office for Research of the University of São Paulo for financial support.
